A Chimeric Plasmodium vivax Merozoite Surface Protein Antibody Recognizes and Blocks Erythrocytic P. cynomolgi Berok Merozoites In Vitro [Microbial Immunity and Vaccines]

This study provides support for a new multiantigen-based paradigm rPvMSP8+1 to explore potential chimeric vaccine candidates against P. vivax malaria using sister species P. cynomolgi.

Source: Infection and Immunity - January 19, 2021 Category: Infectious Diseases Authors: Shen, F.-h., Ong, J. J. Y., Sun, Y.-f., Lei, Y., Chu, R.-l., Kassegne, K., Fu, H.-t., Jin, C., Han, E.-T., Russell, B., Han, J.-H., Cheng, Y. Tags: Microbial Immunity and Vaccines Source Type: research